Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial

Hindley A 1 , Zain Z 2 , Wood L 3 , Whitehead A 4 , Sanneh A 5 , Barber D 5 Show all authors , Hornsby R 5

Affiliations 

  • 1 Rosemere Cancer Centre, Royal Preston Hospital, Preston, United Kingdom. Electronic address: andrew.hindley@lthtr.nhs.uk
  • 2 College of Arts and Sciences, Universiti Utara Malaysia, Kedah, Malaysia
  • 3 Department of Social Sciences, Lancaster Medical School, Lancaster, United Kingdom
  • 4 Medical and Pharmaceutical Statistics Research Unit, Lancaster University, Lancaster, United Kingdom
  • 5 Rosemere Cancer Centre, Royal Preston Hospital, Preston, United Kingdom
Int J Radiat Oncol Biol Phys, 2014 Nov 15;90(4):748-55.
PMID: 25585779 DOI: 10.1016/j.ijrobp.2014.06.033

Abstract

We wanted to confirm the benefit of mometasone furoate (MF) in preventing acute radiation reactions, as shown in a previous study (Boström et al, Radiother Oncol 2001;59:257-265).

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications